Amyloidosis with Cardiac Involvement: Identification, Characterization, and Management.

Current Hematologic Malignancy Reports
Faizi Jamal, Michael Rosenzweig

Abstract

Amyloidosis is a protein deposition disease whereby a variety of precursor proteins form insoluble fibrils that deposit in tissues, causing organ dysfunction and, many times, death. Accurate characterization of the disease based on the nature of the precursor protein, organ involvement, and extent of disease is paramount to guide management. Cardiac amyloidosis is critical to understand because of its impact on prognosis and new treatment options available. New imaging methods have proven to be considerably valuable in the identification of cardiac amyloid infiltration. For treating clinicians, a diagnostic algorithm for patients with suspected amyloidosis with or without cardiomyopathy is shown to help classify disease and to direct appropriate genetic testing and management. For patients with light chain disease, recently introduced treatments adopted from multiple myeloma therapies have significantly extended progression-free and overall survival as well as organ response. In addition, new medical interventions are now available for those with transthyretin amyloidosis. Although cardiac amyloidosis contributes significantly to the morbidity and mortality associated with systemic disease, new tools are available to assist wit...Continue Reading

References

Jan 1, 1974·Annual Review of Medicine·G G Glenner, W D Terry
Sep 1, 1969·Proceedings of the Society for Experimental Biology and Medicine·L BonarM M Skinner
Nov 1, 1994·Histopathology·S Y Tan, M B Pepys
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·M B PepysJ Herbert
Sep 26, 1997·The New England Journal of Medicine·R H FalkM Skinner
Jan 5, 2005·Circulation·Alicia Maria MaceiraDudley John Pennell
Sep 28, 2005·Circulation·Rodney H Falk
Nov 21, 2007·Haematologica·Efstathios KastritisMeletios A Dimopoulos
Feb 15, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shaji KumarMorie A Gertz
Jun 27, 2012·Haematologica·Andrew J CowanVaishali Sanchorawala
Oct 24, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giovanni PalladiniGiampaolo Merlini
Feb 22, 2013·Orphanet Journal of Rare Diseases·Yukio AndoFabrizio Salvi
Dec 26, 2013·JAMA : the Journal of the American Medical Association·John L BerkUNKNOWN Diflunisal Trial Consortium
May 21, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Sharmila DorbalaRodney H Falk
Jul 22, 2014·Human Mutation·Dorota M RowczenioAshutosh D Wechalekar
Sep 30, 2014·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Jean D SipePer Westermark
Jan 1, 2016·Lancet·Ashutosh D WechalekarPhilip N Hawkins
Nov 3, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·W Phillip LawArnold C T Ng
Jul 9, 2016·Journal of the American College of Cardiology·Mathew S MaurerUNKNOWN THAOS Investigators
Aug 29, 2016·JACC. Cardiovascular Imaging·Sameer RainaTarun Pandey
Dec 14, 2016·Annual Review of Pathology·Ahmet Dogan
Apr 17, 2017·JACC. Cardiovascular Imaging·Ana Martinez-NaharroMarianna Fontana
Jun 13, 2017·European Heart Journal·Candida Cristina QuartaJulian D Gillmore
Jul 22, 2017·Journal of the American College of Cardiology·Ana Martinez-NaharroMarianna Fontana
Mar 8, 2018·European Journal of Nuclear Medicine and Molecular Imaging·Eve PiekarskiFrancois Rouzet
Jul 5, 2018·The New England Journal of Medicine·David AdamsOle B Suhr
Jul 5, 2018·The New England Journal of Medicine·Merrill D BensonTeresa Coelho
Oct 3, 2018·Rheumatic Diseases Clinics of North America·Riccardo Papa, Helen J Lachmann
Oct 20, 2018·Journal of the American College of Cardiology·Brett W SperryMazen Hanna

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Amyloidosis

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Discover the latest research on cardiac amyloidosis here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Current Problems in Cardiology
Brandt L Esplin, Morie A Gertz
Expert Opinion on Pharmacotherapy
R SpoladoreG Fragasso
The Canadian Journal of Cardiology
Kevin M Alexander, Ronald M Witteles
© 2021 Meta ULC. All rights reserved